Cauchon M - Search Results

1

[Among patients with mild ischemic stroke or high-risk TIA, does combined clopidogrel-aspirin therapy initiated within 72hours after stroke onset and given for 21 days reduce the recurrence of stroke at 90 days compared to aspirin alone, and is it safe?].

Lanthier L, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2024 Apr;45(4):251-252. doi: 10.1016/j.revmed.2024.02.002. Epub 2024 Feb 22. Rev Med Interne. 2024. PMID: 38388304 French. No abstract available.

2

[Among adults with cardiovascular disease and BMI≥27kg/m² but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?].

Lanthier L, Langlois MF, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2024 Mar;45(3):178-179. doi: 10.1016/j.revmed.2024.01.006. Epub 2024 Jan 16. Rev Med Interne. 2024. PMID: 38228454 French. No abstract available.

3

[In a patient undergoing mechanical ventilation for at least 3 days, does a 3-day course of inhaled amikacin reduce the incidence of ventilator-associated pneumonia compared to placebo, and is it safe?].

Lanthier L, Mayette M, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2024 Jan;45(1):55-56. doi: 10.1016/j.revmed.2023.12.002. Epub 2023 Dec 22. Rev Med Interne. 2024. PMID: 38142212 French. No abstract available.

4

Lignes directrices simplifiées de PEER sur les lipides : actualisation 2023: Prévention et prise en charge des maladies cardiovasculaires en soins primaires.

Kolber MR, Klarenbach S, Cauchon M, Cotterill M, Regier L, Marceau RD, Duggan N, Whitley R, Halme AS, Poshtar T, Allan GM, Korownyk CS, Ton J, Froentjes L, Moe SS, Perry D, Thomas BS, McCormack JP, Falk J, Dugré N, Garrison SR, Kirkwood JEM, Young J, Braschi É, Paige A, Potter J, Weresch J, Lindblad AJ. Kolber MR, et al. Among authors: cauchon m. Can Fam Physician. 2023 Oct;69(10):e189-e201. doi: 10.46747/cfp.6910e189. Can Fam Physician. 2023. PMID: 37833093 Free PMC article. French.

5

PEER simplified lipid guideline 2023 update: Prevention and management of cardiovascular disease in primary care.

Kolber MR, Klarenbach S, Cauchon M, Cotterill M, Regier L, Marceau RD, Duggan N, Whitley R, Halme AS, Poshtar T, Allan GM, Korownyk CS, Ton J, Froentjes L, Moe SS, Perry D, Thomas BS, McCormack JP, Falk J, Dugré N, Garrison SR, Kirkwood JEM, Young J, Braschi É, Paige A, Potter J, Weresch J, Lindblad AJ. Kolber MR, et al. Among authors: cauchon m. Can Fam Physician. 2023 Oct;69(10):675-686. doi: 10.46747/cfp.6910675. Can Fam Physician. 2023. PMID: 37833089 Free PMC article.

6

[Does pitavastatine prevent atherosclerotic cardiovascular events in people living with HIV on antiretroviral therapy with low to moderate cardiovascular risk, and is it safe?].

Lanthier L, Plourde ME, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2023 Oct;44(10):579-580. doi: 10.1016/j.revmed.2023.09.001. Epub 2023 Sep 11. Rev Med Interne. 2023. PMID: 37704460 French. No abstract available.

7

[In adults admitted to the intensive care unit for severe community-acquired pneumonia, does adding hydrocortisone to standard treatment reduce 28-days mortality compared to placebo, and is it safe?].

Lanthier L, Mayette M, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2023 Jul;44(7):383-384. doi: 10.1016/j.revmed.2023.04.442. Epub 2023 May 12. Rev Med Interne. 2023. PMID: 37183146 French. No abstract available.

8

Real-World Effectiveness of Nirmatrelvir/Ritonavir on Coronavirus Disease 2019-Associated Hospitalization Prevention: A Population-based Cohort Study in the Province of Quebec, Canada.

Kaboré JL, Laffont B, Diop M, Tardif MR, Turgeon AF, Dumaresq J, Luong ML, Cauchon M, Chapdelaine H, Claveau D, Brosseau M, Haddad E, Benigeri M. Kaboré JL, et al. Among authors: cauchon m. Clin Infect Dis. 2023 Sep 18;77(6):805-815. doi: 10.1093/cid/ciad287. Clin Infect Dis. 2023. PMID: 37149726

9

[In patients with moderate chronic kidney disease, including non-diabetic patients, does empagliflozin provide renal and cardiovascular benefit compared to placebo, and is it safe?].

Lanthier L, Viau-Trudel A, Plourde ME, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2023 Jun;44(6):319-320. doi: 10.1016/j.revmed.2023.03.002. Epub 2023 Apr 10. Rev Med Interne. 2023. PMID: 37045658 French. No abstract available.

10

[In patients hospitalized for acute heart failure, is a strategy combining rapid and close follow-up visits with laboratories (including NT-proBNP) and rapid up-titration of treatments effective and safe?].

Lanthier L, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2023 Feb;44(2):98-99. doi: 10.1016/j.revmed.2022.12.007. Epub 2023 Jan 5. Rev Med Interne. 2023. PMID: 36610875 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page